Piper Sandler raised the firm’s price target on Abacus Life (ABL) to $13 from $12 and keeps an Overweight rating on the shares following quarterly earnings. Given the strength through the first three quarters of the year and the outlook, the firm is increasing its adjusted EBITDA estimate, Piper told investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABL: